Filing Details
- Accession Number:
- 0001179110-10-001214
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-19 12:00:00
- Reporting Period:
- 2010-01-15
- Filing Date:
- 2010-01-19
- Accepted Time:
- 2010-01-19 16:29:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
820237 | Gen Probe Inc | GPRO | Surgical & Medical Instruments & Apparatus (3841) | 330044608 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1230054 | L Henry Nordhoff | Gen-Probe Incorporated 10210 Genetic Center Drive San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-01-15 | 13,715 | $29.53 | 135,441 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-01-15 | 13,715 | $44.95 | 121,726 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-01-15 | 13,715 | $0.00 | 13,715 | $29.53 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,359 | 2010-05-17 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2009, as amended on December 14, 2009.
- The Stock Option became fully vested and exercisable as of August 15, 2007.
- In accordance with the terms of the applicable stock option agreements, the Reporting Person must exercise all outstanding stock options issued to him prior to February 7, 2007 on or before May 17, 2010 (the first anniversary of his retirement as Chief Executive Officer) or all such stock options will expire.